Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-360,100 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
N/A
-178,600 Reduced 33.15%
360,100 $1.77 Million
Q2 2021

Aug 16, 2021

BUY
N/A
60,600 Added 12.68%
538,700 $2.84 Million
Q1 2021

May 17, 2021

BUY
N/A
310,600 Added 185.43%
478,100 $2.3 Million
Q4 2020

Feb 16, 2021

BUY
N/A
77,200 Added 85.49%
167,500 $725,000
Q3 2020

Nov 16, 2020

BUY
N/A
71,100 Added 370.31%
90,300 $372,000
Q2 2020

Aug 14, 2020

BUY
N/A
19,200 New
19,200 $49,000
Q2 2018

Aug 14, 2018

SELL
N/A
-18,900 Closed
0 $0
Q1 2018

May 15, 2018

BUY
N/A
1,300 Added 7.39%
18,900 $452,000
Q4 2017

Feb 14, 2018

BUY
N/A
17,600
17,600 $596,000

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.